| Company Name: |
TargetMol |
| Tel: |
400-821-0310 15002144251 |
| Email: |
xuexiang.shao@tsbiochem.com |
|
| | Butanoic-3,4,4,4-d4 acid, 3-(methyl-d3)-2-oxo-, sodium salt (1:1) Basic information |
| Product Name: | Butanoic-3,4,4,4-d4 acid, 3-(methyl-d3)-2-oxo-, sodium salt (1:1) | | Synonyms: | Butanoic-3,4,4,4-d4 acid, 3-(methyl-d3)-2-oxo-, sodium salt (1:1);α-Ketoisovaleric acid-[d7] sodium salt/Sodium 2-Keto-3-methyl-d3-butyrate-3,4,4,4-d4;α-Ketoisovaleric acid, sodium salt (D?, 98%);α-Ketoisovaleric Acid-[D7] Sodium Salt (Standard) | | CAS: | 2483831-46-3 | | MF: | C5H9NaO3 | | MW: | 140.11 | | EINECS: | | | Product Categories: | | | Mol File: | 2483831-46-3.mol |  |
| | Butanoic-3,4,4,4-d4 acid, 3-(methyl-d3)-2-oxo-, sodium salt (1:1) Chemical Properties |
| CAS Number Unlabeled | 3715-29-5 |
| | Butanoic-3,4,4,4-d4 acid, 3-(methyl-d3)-2-oxo-, sodium salt (1:1) Usage And Synthesis |
| Uses | Sodium 3-methyl-2-oxobutanoate-d7 is the deuterium labeled Sodium 3-methyl-2-oxobutanoate[1]. Sodium 3-methyl-2-oxobutanoate is a precursor of pantothenic acid in Escherichia coli[2][3][4]. | | References | [1] Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. DOI:10.1177/1060028018797110
[2] MAAS WK, et al. alpha-Ketoisovaleric acid, a precursor of pantothenic acid in Escherichia coli. J Bacteriol. 1953 Apr;65(4):388-93. DOI:10.1128/jb.65.4.388-393.1953
[3] Schauder P, et al. Oral administration of alpha-ketoisovaleric acid or valine in humans: blood kinetics and biochemical effects. J Lab Clin Med. 1984 Apr103(4):597-605. PMID:6366097
[4] Coitinho AS, et al. Pharmacological evidence that alpha-ketoisovaleric acid induces convulsions through GABAergic and glutamatergic mechanisms in rats. Brain Res. 2001 Mar 9894(1):68-73. DOI:10.1016/s0006-8993(00)03321-7 |
| | Butanoic-3,4,4,4-d4 acid, 3-(methyl-d3)-2-oxo-, sodium salt (1:1) Preparation Products And Raw materials |
|